Skin Disorders
NEW YORK - Drug developer Celldex Therapeutics Inc.
CHICAGO - Researchers have scored the first big win against melanoma, the deadliest form of skin cancer.
NEW YORK - Pfizer Inc. said Thursday it is reviving development of its melanoma drug tremelimumab through a collaboration with Swiss drugmaker Debiopharm Group.
